TY - JOUR
T1 - Chronic and repeated Chlamydophila pneumoniae lung infection can result in increasing IL-4 gene expression and thickness of airway subepithelial basement membrane in mice
AU - Chen, Chiung Zuei
AU - Yang, Bei Chang
AU - Lin, Tsun Mei
AU - Lee, Cheng Hung
AU - Hsiue, Tzuen Ren
N1 - Funding Information:
This study was support by a grant from the National Science Council (NSC 93-2314-B-006-051). None of the authors has any financial interests related to the material in the manuscript.
PY - 2009/1
Y1 - 2009/1
N2 - Background/Purpose: Chlamydophila pneumoniae infection has been associated with several pulmonary cardiac diseases. However, it has not been explored for its ability to activate the same immunopathologic mechanisms of asthma, namely, a predominant Th2 immune response and structural changes that are termed airway remodeling. This study evaluated immune responses in the lung and airway pathology of BALB/c mice with chronic and repeated C. pneumoniae infections. Methods: Mice were inoculated intranasally with 5 × 106 inclusion-forming units of C. pneumoniae TWAR strain, and re-inoculated at 14 and 42 days after the primary inoculation. Cytokine gene expression in bronchoalveolar lavage (BAL) cells was analyzed by RT-PCR on day 70. Airway pathology was also evaluated by morphometric measurements. Results: A significant increase of interleukin (IL)-4 mRNA was detected in BAL cells in infected mice, and a significant increase in subepithelial basement membrane thickness of the airways was also noted in infected mice as compared with control mice (8.95 ± 0.28 μm vs. 5.54±0.22 μm, p<0.0001). We further analyzed the correlation between IL-4 cytokine expression and the increased subepithelial basement membrane thickness of airways in infected mice. We found that mice with increased IL-4 mRNA expression had significant increases in the thickness of subepithelial basement membrane as compared with mice without increased IL-4 mRNA expression (9.87 ± 0.51 μm vs. 6.49 ± 0.52 μm, p < 0.0001). Conclusion: It is believed that our results demonstrated for the first time that chronic and repeated infections with C. pneumoniae increased IL-4 gene expression and thickness of airway subepithelial basement membrane in mice.
AB - Background/Purpose: Chlamydophila pneumoniae infection has been associated with several pulmonary cardiac diseases. However, it has not been explored for its ability to activate the same immunopathologic mechanisms of asthma, namely, a predominant Th2 immune response and structural changes that are termed airway remodeling. This study evaluated immune responses in the lung and airway pathology of BALB/c mice with chronic and repeated C. pneumoniae infections. Methods: Mice were inoculated intranasally with 5 × 106 inclusion-forming units of C. pneumoniae TWAR strain, and re-inoculated at 14 and 42 days after the primary inoculation. Cytokine gene expression in bronchoalveolar lavage (BAL) cells was analyzed by RT-PCR on day 70. Airway pathology was also evaluated by morphometric measurements. Results: A significant increase of interleukin (IL)-4 mRNA was detected in BAL cells in infected mice, and a significant increase in subepithelial basement membrane thickness of the airways was also noted in infected mice as compared with control mice (8.95 ± 0.28 μm vs. 5.54±0.22 μm, p<0.0001). We further analyzed the correlation between IL-4 cytokine expression and the increased subepithelial basement membrane thickness of airways in infected mice. We found that mice with increased IL-4 mRNA expression had significant increases in the thickness of subepithelial basement membrane as compared with mice without increased IL-4 mRNA expression (9.87 ± 0.51 μm vs. 6.49 ± 0.52 μm, p < 0.0001). Conclusion: It is believed that our results demonstrated for the first time that chronic and repeated infections with C. pneumoniae increased IL-4 gene expression and thickness of airway subepithelial basement membrane in mice.
UR - http://www.scopus.com/inward/record.url?scp=60149109947&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=60149109947&partnerID=8YFLogxK
U2 - 10.1016/S0929-6646(09)60031-0
DO - 10.1016/S0929-6646(09)60031-0
M3 - Article
C2 - 19181607
AN - SCOPUS:60149109947
SN - 0929-6646
VL - 108
SP - 45
EP - 52
JO - Journal of the Formosan Medical Association
JF - Journal of the Formosan Medical Association
IS - 1
ER -